FDA
- Status: approved
the second batch vaccine (the second batch vaccine) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Beijing Chaoyang District Centre for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.